| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Valsartan | FAERS: 4 | US FAERS | |
| 2 | Bosentan | FAERS: 2 | US FAERS | |
| 3 | Clozapine | FAERS: 2 | OFFSIDES US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 5 | Alprazolam | FAERS: 1 | US FAERS | |
| 6 | Arthrotec | FAERS: 1 | US FAERS | |
| 7 | Carbamazepine | FAERS: 1 | US FAERS | |
| 8 | Fenofibrate | FAERS: 1 | US FAERS | |
| 9 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 10 | Sunitinib | FAERS: 1 | US FAERS | |
| 11 | eltrombopag | FAERS: 1 | US FAERS | |
| 12 | gemcitabine | FAERS: 1 | US FAERS | |
| 13 | Buprenorphine | OFFSIDES | ||
| 14 | Letrozole | OFFSIDES | ||
| 15 | Nebivolol | OFFSIDES | ||
| 16 | Zidovudine | OFFSIDES | ||
| 17 | lamivudine, zidovudine drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.